| Tap a line for its trend | Last 12Mto Jun 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 24.97× | 24.97× | 23.79× | 26.15× | 27.61× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| — | — | — | — | 0.18× | ||
| 0.01× | 0.01× | −0.01× | −0.05× | 0.18× | ||
| 0.23× | 0.23× | 0.28× | 0.22× | 494.43× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/06/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 27.61 | 26.15 | 23.79 | 24.97 | 24.97 | |
| Working Capital Turnover | 0.18 | — | — | — | — | |
| Cash Conversion (CFO/Net Income) | 0.18 | -0.05 | -0.01 | 0.01 | 0.01 | |
| CFO/EBITDA | 494.43 | 0.22 | 0.28 | 0.23 | 0.23 |